Journal article
Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis
Abstract
Key Points Is performing a large definitive trial to establish the optimal anticoagulation strategy in dialysis recipients with atrial fibrillation feasible? One hundred fifty-one patients at 28 dialysis centers were enrolled and randomized to apixaban ( n =51), warfarin ( n =52), or no oral anticoagulation ( n =48). Despite coronavirus disease–related pauses, recruitment was completed in 30 months, with 83% of participants completing …
Authors
Harel Z; Smyth B; Badve SV; Blum D; Beaubien-Souligny W; Silver SA; Clark E; Suri R; Mavrakanas TA; Sasal J
Journal
Journal of the American Society of Nephrology, Vol. 36, No. 5, pp. 901–910
Publisher
Wolters Kluwer
Publication Date
5 2025
DOI
10.1681/asn.0000000000000495
ISSN
1046-6673